147 related articles for article (PubMed ID: 8334588)
1. Pathophysiology of cerebellar dysfunction in the Wernicke-Korsakoff syndrome.
Butterworth RF
Can J Neurol Sci; 1993 May; 20 Suppl 3():S123-6. PubMed ID: 8334588
[TBL] [Abstract][Full Text] [Related]
2. Effects of thiamine deficiency on brain metabolism: implications for the pathogenesis of the Wernicke-Korsakoff syndrome.
Butterworth RF
Alcohol Alcohol; 1989; 24(4):271-9. PubMed ID: 2675860
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiologic mechanisms responsible for the reversible (thiamine-responsive) and irreversible (thiamine non-responsive) neurological symptoms of Wernicke's encephalopathy.
Butterworth RF
Drug Alcohol Rev; 1993; 12(3):315-22. PubMed ID: 16840290
[TBL] [Abstract][Full Text] [Related]
4. Activities of thiamine-dependent enzymes in two experimental models of thiamine-deficiency encephalopathy. 2. alpha-Ketoglutarate dehydrogenase.
Butterworth RF; Giguère JF; Besnard AM
Neurochem Res; 1986 Apr; 11(4):567-77. PubMed ID: 3724963
[TBL] [Abstract][Full Text] [Related]
5. [Wernicke-Korsakow syndrome: clinical aspects, pathophysiology and therapeutic approaches].
Preuss UW; Soyka M
Fortschr Neurol Psychiatr; 1997 Sep; 65(9):413-20. PubMed ID: 9417425
[TBL] [Abstract][Full Text] [Related]
6. Thiamine-dependent enzyme changes in the brains of alcoholics: relationship to the Wernicke-Korsakoff syndrome.
Butterworth RF; Kril JJ; Harper CG
Alcohol Clin Exp Res; 1993 Oct; 17(5):1084-8. PubMed ID: 8279670
[TBL] [Abstract][Full Text] [Related]
7. [The Wernicke-Korsakoff syndrome and ataxia in alcoholics].
Silfverskiöld BP
Lakartidningen; 1969 Nov; 66(46):4773-8. PubMed ID: 5375335
[No Abstract] [Full Text] [Related]
8. [Neurological complications associated with vitamin B1 deficiency (thiamine)].
Moltó JM
Rev Neurol; 1996 Apr; 24(128):389-91. PubMed ID: 8721913
[No Abstract] [Full Text] [Related]
9. Three-dimensional mapping of local cerebral perfusion in alcoholic encephalopathy with and without Wernicke-Korsakoff syndrome.
Hata T; Meyer JS; Tanahashi N; Ishikawa Y; Imai A; Shinohara T; Velez M; Fann WE; Kandula P; Sakai F
J Cereb Blood Flow Metab; 1987 Feb; 7(1):35-44. PubMed ID: 3805163
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the role of NMDA-mediated excitotoxicity in the selective neuronal loss in experimental Wernicke encephalopathy.
Todd KG; Butterworth RF
Exp Neurol; 1998 Jan; 149(1):130-8. PubMed ID: 9454622
[TBL] [Abstract][Full Text] [Related]
11. Long-term therapy for the mental disturbances of Wernicke-Korsakoff syndrome.
Harrell HL
J Fla Med Assoc; 1977 Mar; 64(3):165-7. PubMed ID: 845586
[No Abstract] [Full Text] [Related]
12. L-2-chloropropionic acid-induced neurotoxicity is prevented by MK-801: possible role of NMDA receptors in the neuropathology.
Widdowson PS; Wyatt I; Gyte A; Simpson MG; Lock EA
Toxicol Appl Pharmacol; 1996 Jan; 136(1):138-45. PubMed ID: 8560467
[TBL] [Abstract][Full Text] [Related]
13. Cerebral atrophy and hypoperfusion improve during treatment of Wernicke-Korsakoff syndrome.
Meyer JS; Tanahashi N; Ishikawa Y; Hata T; Velez M; Fann WE; Kandula P; Mortel KF; Rogers RL
J Cereb Blood Flow Metab; 1985 Sep; 5(3):376-85. PubMed ID: 4030916
[TBL] [Abstract][Full Text] [Related]
14. Thiamine deficiency and the intrinsic opioids in the Wernicke-Korsakoff syndrome.
Iacono RP; Sandyk R
J Cereb Blood Flow Metab; 1986 Oct; 6(5):630-1. PubMed ID: 3760048
[No Abstract] [Full Text] [Related]
15. Thiamine deficiency results in metabolic acidosis and energy failure in cerebellar granule cells: an in vitro model for the study of cell death mechanisms in Wernicke's encephalopathy.
Pannunzio P; Hazell AS; Pannunzio M; Rao KV; Butterworth RF
J Neurosci Res; 2000 Oct; 62(2):286-92. PubMed ID: 11020221
[TBL] [Abstract][Full Text] [Related]
16. Wernicke-Korsakoff syndrome.
Zubaran C; Fernandes JG; Rodnight R
Postgrad Med J; 1997 Jan; 73(855):27-31. PubMed ID: 9039406
[TBL] [Abstract][Full Text] [Related]
17. Thiamine utilization in the pathogenesis of alcohol-induced brain damage.
Martin PR; Pekovich SR; McCool BA; Whetsell WO; Singleton CK
Alcohol Alcohol Suppl; 1994; 2():273-9. PubMed ID: 8974347
[TBL] [Abstract][Full Text] [Related]
18. Reversible alterations of cerebral gamma-aminobutyric acid in pyrithiamine-treated rats: implications for the pathogenesis of Wernicke's encephalopathy.
Héroux M; Butterworth RF
J Neurochem; 1988 Oct; 51(4):1221-6. PubMed ID: 3418348
[TBL] [Abstract][Full Text] [Related]
19. Wernicke-Korsakoff encephalopathy.
Pearce JM
Eur Neurol; 2008; 59(1-2):101-4. PubMed ID: 17934284
[TBL] [Abstract][Full Text] [Related]
20. Wernicke-Korsakoff syndrome.
Br J Hosp Med; 1984 Jan; 31(1):82. PubMed ID: 6697048
[No Abstract] [Full Text] [Related]
[Next] [New Search]
